Enm Holdings Ltd. (SEHK:128) acquired 1.33% stake in PuraPharm Corporation Limited from Chan Yu Ling Abraham for HKD 10 million on December 31, 2014. Enm will acquire 12,557 shares and already holds 45,246 shares. The purchase price payment shall be settled by Enm at completion. For the year ended December 31, 2013, PuraPharm reported net profit before taxation and extraordinary items of HKD 22.56 million, net profit after taxation and extraordinary items of HKD 18.85 million and net assets of HKD 53.84 million.

The completion of transaction is subject to all corporate approvals of Chan Yu Ling Abraham and PuraPharm, third party approvals, receipt by Cosy Good of unaudited consolidated management account of PuraPharm for the period from January 1, 2014 to October 31, 2014 and draft consolidated financial statements of PuraPharm as at and for the fiscal year ended December 31, 2013 (with comparative figures of the fiscal year ended December 31, 2012) audited by an audit firm, with a confirmation letter issued by the audit firm to the board of directors of PuraPharm and waiver by an existing shareholder of PuraPharm of its pre-emptive right. The transaction is expected to close on or before December 31, 2014.

Enm Holdings Ltd. (SEHK:128) completed the acquisition of 1.33% stake in PuraPharm Corporation Limited from Chan Yu Ling Abraham on December 31, 2014.